12 -PGJ2, 12 -prostaglandin J2; AIF, apoptosisinducing factor; Sox-4, SRY-HMG box protein-4; z-VAD-fmk, Benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone
Introduction
12 -Prostaglandin(PG) J2 is a cyclopentenone prostaglandins(PGs) which were known to have antiproliferative effects on various tumour cell growth (Kim et al., 1993; Kim et al., 2002) .
12 -PGJ2 is an enzymatic dehydration product of PDJ2 (Fukushima et al., 1982; Fukushima et al., 1994) and 12 -PGJ2 was able to induce apoptosis in HeLa cells via caspase activation . PGs are also reported to regulate expression of variable genes, including Sox-4 (Ahn et al., 2002) , Ssf-1 (Ahn et al., 1999) , c-myc and hsp70 (Ahn et al., 1998) , and these genes seem to positively or negatively regulate the cell death in many tumour cells.
12 -PGJ2-induced Sox-4 is one of the Sox (SRY-HMG box containing) proteins which are assumed to be involved in the regulation of developmental stages in several tissues. As a transcription factor containing serine-rich trans-activation domain, Sox-4 was selectively expressed in liver and thymus (van de Wetering et al., 1993) . Sox-4 expression was induced during 12 -PGJ2-induced apoptosis (Ahn et al., 1999; and demonstrated to induce apoptosis directly (Hur et al., 2004) . Sox-4 is thought to be an important mediator of apoptosis, but its actual process is not clarified yet.
Mitochondria is emerging as the key regulator of apoptosis. Most of the mechanisms characterized appeared to indicate intimate involvement of signaling via mitochondria. Two different pathways have been exerted (Ly et al., 2003; Maria et al., 2003; Tomomi et al., 2003; Xavier et al., 2004) ; one is the caspase cascade, activation of cysteine-aspartic acid proteases through mitochondrial factor, cytochrome c, and this process is regulated by bcl-2 family, and the other is an apoptotsis inducing factor (AIF), which is known to trigger apoptotic mitochondrial events and respon-sible for caspase-independent nuclear fragmentation via unknown processes (Stuart et al., 2002; Sean et al., 2004) . Process of AIF is not examined closely enough, but bcl-2 overexpression is known to inhibit translocation of AIF. Generally those two pathways were thought to work independently, and which signaling pathway should be utilized is up to various conditions, cell types and sorts of stimuli, etc. Some cases reported that both caspases and AIF were activated in same stimuli (David et al., 2001; Isabel et al., 2001; Sai et al., 2001; Tong et al., 2004; Xu et al., 2004) . Some of the apoptotic stimuli pass through the caspase-dependent and AIF-independent pathway (Ella et al., 1998; Neeru et al., 2004) or caspase-independent and AIF-dependent (Sean et al., 2002; Bains et al., 2003; , and others reported that ROS production is implicated in CD47-mediated cell death without cytochrome c nor AIF release (Gael et al., 2003) . Moreover, Damien et al. reported that mitochondrial release of AIF might occur downstream of cytochrome c release (Damien et al., 2002; Damien et al., 2003) . In this study, the mechanisms of 12 -PGJ2-induced apoptosis pathway in HeLa cells was investigated specifically focusing on two mitochondrial factors, bcl-2 for the caspase-dependent pathway and AIF for the caspase-independent pathway. And also we observed the effect of Sox-4 in 12 -PGJ2-induced apoptosis, for 12 -PGJ2-induced Sox-4 expression was reported to induce the apoptosis directly.
M aterials and M ethods Reagents
12 -PGJ2 was obtained from BioMol (Plymouth Meeting, PA) and pan-caspase inhibitor Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (z-VADfmk) was from Enzyme Systems Products (Livermore, CA). Protease inhibitor cocktail was from Roche Molecular Biochemicals (Mannheim, Germany). Agonistic anti-Fas antibody (CH11) and antagonistic anti-Fas antibody (ZB4) were from Upstated Biotechnology (Lexington, KY). 3-(4,5-Dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) and Hoechst 33342 were from Sigma (St. Louis, MO). Anti-caspase 3, -8, -9 antibodies were from Cell Signaling Technology (Beverly, MA), anti-cytochrome c, AIF, heat-shock protein(hsp)60 antibodies were from Santa Cruz (Santa Cruz, CA) and anti-Bcl-2 was from Delta Biolabs (Campbell, CA). Anti-Sox-4 antibody was manufactured in Koma Biotech (Seoul, Korea) using synthetic Sox-4 protein. Horseradish peroxidase(HRP)-conjugated secondary antibody against rabbit and mouse IgG and anti--actin were from Sigma. FITClabeled and Texas Red-labeled secondary antibodies were all from Santa Cruz. Unless specified otherwise, all reagents were purchased from Sigma.
C ell culture and viability assay Human cervical carcinoma HeLa cells were obtained from American Type Culture Collection (ATCC, Rockville, MD) and maintained in RPMI 1640 media supplemented with 10% heat-inactivated (56 o C for 30 min) fetal bovine serum (Hycloned Laboratories Inc., Logan UT) and 100 U/ml of penicillin/streptomycin (Gibco BRL, Grand Island, NY) at 37 o C in a humidified atmosphere of 5% CO2. HeLa cells stably overexpressing bcl-2 protein, HeLa B4, were gift from Prof. Lee and maintained in complete medium containing 0.5 µg/ml G418 (Gibco, Grand Island, NY).
To observe the effect of 12 -PGJ2 on the growth of HeLa and HeLa B4 cells, cell viability was determined by MTT assay. In brief, cells were plated in 96-well plates and then treated with indicated concentrations of 12 -PGJ2. After incubation of indicated time, MTT reagent was added to final concentration of 500 µg/ml. Three hours later, MTT crystals were collected and dissolved with isopropanol containing 0.04 N of HCl and the absorbance was measured at 570 nm.
Evaluation of apoptosis
Induction of apoptosis was determined by fragmentation of genomic DNA. Cells were treated with 30 µM of 12 -PGJ2 for indicated times, and then genomic DNA was extracted using DNA extraction buffer [5 mM Tris-Cl pH 8.0, 20 mM EDTA pH 8.0, 1% sodium dodecyl sulfate (SDS), 50 µg/ml proteinase K] and extraction with phenol-ethanol was followed. DNA pellets were dissolved in TE buffer (10 mM Tris-Cl pH 8.0 1 mM EDTA pH 8.0) containing 20 µg/ml of RNase A and incubated at 37 o C for 1 h. 5 µg of DNA was separated on 1.8% agarose gels with 1X TAE (20 mM Tris-acetate, 1 mM EDTA). DNA in the gel was stained with ethidium bromide and visualized under UV light and photographed.
W estern blot analysis
Cells were harvested and lysed with RIPA buffer[1% Triton X-100, 20 mM Tris-Cl, pH 7.5, 150 mM NaCl, 0.5% deoxycholate, 0.1% SDS, 1 mM EDTA] containing protease inhibitor cocktail. 30 µg of each protein was separated in 12-15% SDS-polyacrylamide gel (PAGE), and transferred to a nitrocellulose membrane in transfer buffer [25 mM Tris base, 193 mM glycine, 20% methanol]. The membrane was blocked in 5% nonfat dried milk in phosphate-buffered saline (PBS) and then incubated with primary antibody in blocking solution at 4 o C, followed by extensive washing in PBS containing 0.1% Tween-20. The blot was then incubated with peroxidase-conjugated secondary antibody in blocking solution at room temperature, followed by washing in PBS containing 0.1% Tween-20. Antigen was detected using the enhanced chemiluminescence western blotting detection system(Amersham-Pharmarcia, Buckinhamshire, UK).
Im m unofluorescence m icroscopy
Cells were grown on coverslips and incubated with 12 -PGJ2 and z-VAD-fmk for indicated times. Cells were fixed with 100% ice-cold methanol and then blocked with blocking buffer [10% fetal bovine serum, 1% Albumin, bovine serum (BSA), 0.02% sodium azide, 1×PBS] for 1 h at room temperature. Anti-AIF, anit-cytochrome c and anti-hsp 60 antibodies were diluted and applied to coverslips and incubated overnight at 4 o C. Coverslips were washed with 1×PBS, then FITC-labeled and Texas red-labeled second antibodies were applied and incubated for 1 h at room temperature keeping in the dark. After washing with 1×PBS, Hoechst 33342 was incubated in final 10 µM for 5 min, mounted on slides and observed under a Carl Zeiss LSM510 confocal microscope.
Flow cytom etry analysis
To evaluate ψm, cells were treated with 30 µM of 12 -PGJ2 and z-VAD-fmk for indicated times, then 10 µg/ml of 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolecarbo-cyanine (JC-1; Molecular Probes, Eugene, OR) was treated for 10 min at room temperature. Cells were finally washed with 1×PBS, resuspended in 200 µl of 1×PBS and analyzed using FACScan flow cytometer (Becton Dickinson).
R esults Effect of bcl-2 overexpression on 12 -PG J2-induced apoptosis
Ability of HeLa B4 cells to express bcl-2 stably was confirmed by western blot method. In Figure 1A , HeLa B4 cells clearly showed bcl-2 protein overexpressed in comparison with HeLa cells. Bcl-2 known to inhibit apoptosis was induced by various stimuli and its effect on 12 -PGJ2-induced apoptosis was determined measuring growth inhibition curve ( Figure 1B) . The cells were treated with 12 -PGJ2 for indicated time period and MTT assay was performed. Overex- attenuation of the apoptosis induced by 12 -PGJ2, was in effect for 24 h period. After 24 h, inhibition of bcl-2 was abolished and growth rate dropped rapidly. In case of cisplatin induced apoptosis, inhibition by bcl-2 was effective for 48 h, more than 50% of cells were kept alive (data not shown). This result shows that 12 -PGJ2-induced apoptosis is mainly dependent to mitochondrial pathway, but there might be another pathway which does not associate with bcl-2 path.
Depolarization of m itochondrial potential ψ m
In order to determine mitochondrial integrity, the changes of ψm depolarization were measured. Cells were stained with the fluorescent dye JC-1, and the flow cytometric assays were done (Figure 2 ). JC-1 exhibits potential-dependent accumulation in mitochondria. When mitochondrial depolarization proceeds in early stages of apoptosis, fluorescence of JC-1 turns from red to green. Figure 2A shows the results of the induced mitochondrial depolarization at 12 h in HeLa cells treated with 30 µM of 12 -PGJ2, and this process was completed at 24 h. In HeLa B4 cells, 12 -PGJ2-induced depolarization was attenuated for 12 h, but bcl-2 effect of maintaining ψm was abolished in 24 h. FL2 (red) fluorescence shows the aggregated forms of JC-1 which reflects ψm, and is shown on Figure 2B . Histograms show more apparentl reduction of red fluorescences. Pretreatment of the cells with z-VAD-fmk also inhibited depolarization of ψm for 24 h. These results imply that 12 -PGJ2-induced ψm depolarization is downstream of caspase cascades, and suggests the existence of upstream caspases in mitochondria in 12 -PGJ2-induced apoptosis.
Effect of bcl-2 overexpression in caspase-independent pathw ay; AIF AIF is known as another pathway that lead cells to apoptosis independently with caspase cascade. To test whether AIF pathway is involved in 12 -PGJ2-induced apoptosis, HeLa and HeLa B4 cells were treated with 30 µM of 12 -PGJ2, and subcellular localization of AIF was tested by immunofluorescence microscopy ( Figure 3 ). As shown in Figure 3 , AIF was neither released to cytosolic fraction nor redistributed to nuclei. Also in HeLa B4 cells, overexpression of bcl-2 had no effects on AIF translocation. AIF was thought not to involve in 12 -PGJ2-induced apoptosis, and we could not find any signs of release of AIF from mitochondria to cytosol.
Effect of bcl-2 overexpression in caspase-dependent pathw ay
Cytochrome c released from the effected mitochondria was examined by immunofluorescence microscopy in 12 -PGJ2-induced apoptosis. As shown in Figure 4 , cytochrome c was released to cytosolic fraction in HeLa cells but in HeLa B4 cells overexpressing bcl-2, cytochrome c release was blocked in the same time period. This result affirms that Bcl-2 overexpression inhibited cytochrome c release in 12 -PGJ2-induced apoptosis.
In addition, in the HeLa B4 cells treated with 30 µM of 12 -PGJ2 caspase activity was not observed till 12-18 h ( Figure 5 ), suggesting that bcl-2 blocked cytochrome C mediated caspase activation. In previous study, caspases were found to be activated in 9-12 h in HeLa cells . In contrary, cisplatin induced caspase activation was almost completely blocked for 48 h (data not shown). These results demonstrate that bcl-2 was not able to block 12 -PGJ2-induced apoptosis completely. Since caspase 8 was known to be activated slightly after caspase 9 and caspase 3 activation, we investigated whether caspase 8-activating Fas pathway was switched on. Caspase 8 can be activated in two pathways; one is Fas receptor-ligand interaction and the other is caspase 3-activated pathway. As shown in Figure 6 , ZB4, the antagonistic Fas-antibody, blocked caspase 8 activation by agonistic Fas antibody CH11, but not that of 12 -PGJ2. These results represented that caspase 8 activation in 12 -PGJ2-induced apoptosis was through caspase 3-capsase 8 acticvation loop, and Fas receptor-ligand interaction was not involved.
We observed that 12 -PGJ2-induced apoptosis in HeLa cells certainly activated caspase cascade in cluding cytochrome c and caspase 9-caspase-3 amplication loop, and both events were inhibited by bcl-2 overexpression.
Expression of Sox-4
12 -PGJ2 was shown to up-and down-regulate many apoptosis-related factors. Sox-4 is one of these molecules, and was found to act directly as regulator of apoptosis. Expression of Sox-4 was analyzed by either transfection of Flag-tagged Sox-4 or Western blot in HeLa. As shown in Figure 7C , both Sox-4 antibody and Flag-tag antibody revealed overexpressed signal at about 70 kDa. Estimated molecular weight of Sox-4 protein is 47.5 kDa, but those Sox-4 protein expressed in mammalian cells consistently appeared as 70 kDa molecule. Such discrepancy in molecular size of Sox-4 may be due to post-translational modification of Sox-4. As shown in Figure 7A and B, Sox-4 was expressed in HeLa and HeLa B4 cells respectively induced by 12 -PGJ2, and its expression was not attenuated in HeLa B4 cells. Sox-4 was reported to evoke apoptosis directly, and its expression pattern was coincident with other apoptotic events.
D iscussion
Mitochondria have been noticed as heart of various forms of cell death, specially after findings of mitochondrial factors which involved in apoptosis regula- Figure 6 . Involvement of Fas receptor in 12 -PGJ2-induced caspase 8 activation. HeLa B4 cells were pretreated with or without 500 ng/ml of ZB4, the antagonistic Fas-antibody, and then treated with 1 µg/ml of agonistic Fas-antibody CH11 and 30 µM of 12 -PGJ2. Western blotting was done with caspase 8 antibody, and cell viability was examined by MTT assay. Histogram represents the mean ± SD of three independent experiments. P 0.01, compared to control. Fas indicates for agonistic Fas-antibody CH11, 12 -PGJ2 for 12 -PGJ2 and ZB4 for antagonistic Fas-antibody ZB4. tion. Bcl-2 family has been the standout molecule focused as anti-apoptotic regulators which are related to caspase cascade (Atan et al., 1999; Yoshihide et al., 2003) . In addition numerous other proteins, DIABLO/SMAC (Stacy et al., 2002) , AIF Santos et al., 1999; Eric et al., 2000; , endonuclease G Parrish et al., 2001; van Loo et al., 2001) , were reported as apoptosis regulators which might act in caspasedependent or -independent manner. In murine glioma GL261 cells, CDK inhibitor, flavopiridol, accompanied the release of cytochrome c together with translocation of AIF (Newcomb et al., 2003) . And in cells from patients of B cell chronic lymphocytic leukemia and human leukemic cell lines, apoptosis were induced by cladribine activated caspase cascade and translocated AIF to nuclei at the same time (Isabel et al., 2001; Perez-Galan et al., 2002) . These reports lead us to exam ine the m itochondrial pathways of 12 -PGJ2-induced apoptosis in HeLa cells.
In previous study, 12 -PGJ2-induced apoptosis in HeLa cells was accompanied with the release of cytochrome c and activation of caspase cascade suggesting that 12 -PGJ2-induced apoptosis in HeLa cells involves an activated cytochrome c-dependent pathway. To study the mechanism of 12 -PGJ2-induced apoptosis in Hela Cells, we examined caspase-independent pathway together with bcl-2 effects on caspase cascade.
12 -PGJ2 can exert its ability in many ways; through activation of caspase-1 (Ahn et al., 2002) or induce apoptosis regulators, like Sox-4, which directly plays a role in apoptosis (Hur et al., 2004) . In the case of 15-deoxy--12,14-PGJ2(15d-PGJ2), the hydrolysis product of 12 -PGJ2, CHOP gene was transcriptionally activated to induce apoptosis (Shoichi et al., 2003) . In 12 -PGJ2-induced apoptosis in HeLa cells, bcl-2 overexpression results were in agreement with other previous reports of Bcl-2 overexpression blockage of caspase activation and attenuated apoptosis. And AIF, another new regulator of caspase-independent pathway was not activated. M echanism of 12 -PGJ2-induced apoptosis was clearly caspase-dependent, AIF-independent pathway. z-VAD-fmk study showed unexpected results. As a general caspase inhibitor, z-VAD-fmk usually inhibits caspase cascade in its downstream events. But as shown in Figure 2 , z-VAD-fmk inhibited depolarization of ψm, the earliest events in 12 -PGJ2-induced apoptosis. In this case ψm depolarization was apparently upstream of caspase 9-caspase 3 cascade. We reasoned that another caspase, excluding caspase 9, might exist upstream of mitochondria, activated by 12 -PGJ2 or protein induced. In fact, caspase 8, -2 or -1 were reported to be the upstream of ψm dissipation. In an example, preotease activity of caspase 2 seems to be required as upstream of ψm dissipation (Patrice et al., 2002; Yin et al., 2002) .
Prostaglandins and many other inflammatory stimuli induce the expression of genes.
12 -PGJ2 seems to accumulate in ER (Senye et al., 1998) , and PGinduced stress-protein gene expression requires de novo protein synthesis (Koizumi et al., 1993; Odani et al., 1996) . This suggests that 12 -PGJ2-induced apoptosis also requires the newly synthesized proteins.
12 -PGJ2 especially induces Sox-4 protein and this phenom enon is restricted only to 12 -PGJ2, but not to cisplatin (data not shown). Sox-4 was shown to be overexpressed in HepG2 and Hep3B cells by 12 -PGJ2 and induced apoptosis through activation of caspase 1 (Ahn et al., 2002) . Also GRR (Gly rich region) region of Sox-4 was proved to induce apoptosis directly for itself (Eun-Hae Hur, unpublished) . Based on these preliminary information, we made an attempt to examine the expression of Sox-4 in HeLa and HeLa B4 cells. Both HeLa and HeLa B4 cells expressed Sox-4 at 12 h, keeping its levels till the apoptosis completed. It is possible to assume that apoptosis-inducing ability of Sox-4 might be attenuated by bcl-2 although expression of Sox-4 was not affected by bcl-2 protein. And this suggests that Sox-4 protein might have an influence on mitochondria signaling pathway somehow. z-VAD-fmk results which inhibit the dissipation of ψm suggested that Sox-4 might be activating the casapses which exist in upstream of mitochondria.
This supposition might explain how z-VAD-fmk can block dissipation of ψm in 12 -PGJ2-induced apoptosis in HeLa cells. Also complete inhibition of ψm depolarization by z-VAD-fmk suggests that early events of 12 -PGJ2-induced apoptosis might be solely dependent on caspases. It seemed that no other caspase-independent pathway, AIF, might participate in 12 -PGJ2-induced apoptosis. But it should be proved that 12 -PGJ2 or Sox-4 might be able to disrupt ψm of isolated mitochondria directly. In addition, upstream caspases which were thought to be involved in 12 -PGJ2-induced apoptosis should be proved more closely. Supposing the existence of upstream caspases should be the acceptable answer for the blocking of z-VAD-fmk to ψm, if it does exist, in 12 -PGJ2-induced apoptosis. In conclusion, our data suggested that 12 -PGJ2-induced apoptosis utilized a caspase-dependent, AIFindependent pathway in HeLa cells. Anti-apoptotic bcl-2 protein partially attenuated cell death, including depolarization of ψm, release of cytochrome c and activation of caspases, and this processes might be regulated by 12 -PGJ2-induced Sox-4 protein.
